Tag Archives: FDA
Advances in science and technology have brought about a new wave of promising cancer immunotherapies, which harness the body’s immune system to detect and fight cancer. Researchers have coined immunotherapy as the “beginning to the end of cancer” and we continue to see the space flourish.
Continue reading →
I had the great privilege of speaking with Cheddar about the importance of cancer immunotherapy and OncoSec’s role in the fight to end cancer. We discuss the advantages of intratumoral therapy, the future of cancer care, and how OncoSec is positioned to solve a great unmet need in oncology. Check out the full interview for more!